Petlife Pharmaceuticals, Inc.
PTLF · OTC
2/28/2018 | 11/30/2017 | 8/31/2017 | 5/31/2017 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.01 | -0.01 | 0 | -0.01 |
| % Growth | 0% | – | 100% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |